Tailored telehealth cognitive behavioral therapy is superior to education for improving quality of life and pelvic pain in endometriosis.

Secondary analysis of the RESOLVE trial suggests the benefits of graded sensorimotor retraining across patient groups with chronic low back pain.

GLP-1 receptor agonists appear to be associated with an increased risk for osteoporosis and other orthopedic conditions.

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ACR20 response rates.

GLP-1 receptor agonist (GLP-1 RA) use was found to be associated with reduced risk for substance use disorders.

With an increase in access to e-bikes, researchers observed a corresponding increase in adolescent traumatic injuries related to e-bikes.